Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Palo Alto Investors

Investor type Investment Bank
Founders Will Edwards

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 30
Average round size
info
The average size of a deal this fund participated in
$29M
Portfolio companies 19
Rounds per year 0.94
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.37
Exits 12
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
Summary

Palo Alto Investors is the famous Corporate Investor, which was founded in 1989. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Palo Alto.

The current fund was established by Will Edwards. Besides them, we counted 3 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Palo Alto Investors, startups are often financed by Vivo Capital, BioAdvance, Venrock. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Third Point Ventures, Technology Partners. In the next rounds fund is usually obtained by Kleiner Perkins, Vivo Capital, Mobius Venture Capital.

The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. Comparing to the other companies, this Palo Alto Investors performs on 17 percentage points more the average number of lead investments. The important activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Semiconductor, Biotechnology. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Deem, NewLeaf Symbiotics, SkyPilot Networks.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Palo Alto Investors:
Typical Co-investors
Palo Alto Investors is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Palo Alto Investors:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BACH Wirtschafts-Consulting -
Huihai Junrui Information Consulting Center China, Hangzhou, Zhejiang
KBR Global Acquisition Fund SPC -
Leiting Games China, Guangdong, Shenzhen
MBU Capital England, London, United Kingdom
Monte Carlo Capital China, Hong Kong, Hong Kong Island
Otimo Retail Canada, Montréal, Quebec
SSM Partners Memphis, Tennessee, United States
Teall Capital North Carolina, United States, Winston Salem
ZIG Ventures Central, Central Region, Singapore

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Health Care
Medical
Pharmaceutical
$27M06 May 2021 New York, New York, United States

NewLeaf Symbiotics

Agriculture
Biotechnology
Sustainability
$17M15 Sep 2014 City of Saint Louis, Missouri, United States

NeXeption

Biopharma
Biotechnology
Health Care
$21M02 Jan 2014 Pennsylvania, United States

Alimera Sciences

Biotechnology
Drug Discovery
Health Care
Medical
Pharmaceuticals
$40M18 Jul 2012 Georgia, United States

Ceptaris Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$10M05 Jun 2012 Pennsylvania, United States

Ceptaris Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$14M11 Aug 2011 Pennsylvania, United States

Revance Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$45M10 Jun 2011 United States, " United States"}

Fisker Automotive

Automotive
Autonomous Vehicles
Electric Vehicle
Manufacturing
Mobile
Transportation
$150M22 Feb 2011 Torrance, California, United States

Revance Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$25M28 Dec 2009 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Palo Alto Investors?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: